IMDX (Insight Molecular Diagnostics) Interest Expense: $-0.10 Mil (TTM As of Mar. 2026)

What is Insight Molecular Diagnostics Interest Expense?

Insight Molecular Diagnostics IMDX -3.23% 49 Interest Expense is $-0.10 Mil as of Mar. 2026. GuruFocus rates IMDX with a GF Score™ of 49/100 and a GF Value™ of $1.26 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Insight Molecular Diagnostics's interest expense for the three months ended in Mar. 2026 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Insight Molecular Diagnostics's Operating Income for the three months ended in Mar. 2026 was $ -10.33 Mil. Insight Molecular Diagnostics's Interest Expense for the three months ended in Mar. 2026 was $ -0.02 Mil. Insight Molecular Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Insight Molecular Diagnostics (NAS:IMDX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Insight Molecular Diagnostics's Interest Expense for the three months ended in Mar. 2026 was $-0.02 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-10.33 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1.31 Mil.

Insight Molecular Diagnostics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Insight Molecular Diagnostics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Insight Molecular Diagnostics Interest Expense Historical Data

* Premium members only.

The historical data trend for Insight Molecular Diagnostics's Interest Expense can be seen below:

Insight Molecular Diagnostics Interest Expense Chart

Insight Molecular Diagnostics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.21

-0.08

-0.05

-0.08

-0.11

Insight Molecular Diagnostics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.03	-0.03	-0.03	-0.03	-0.02

49GF Score

Insight Molecular Diagnostics Inc IMDX

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Insight Molecular Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.10 Mil mean?

Insight Molecular Diagnostics (IMDX) has a Interest Expense of $-0.10 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Insight Molecular Diagnostics and its competitors.

Is Insight Molecular Diagnostics' Interest Expense too high?

Insight Molecular Diagnostics' current Interest Expense is $-0.10 Mil. Overall, Insight Molecular Diagnostics has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Insight Molecular Diagnostics' Interest Expense compare to BDSX and XGN?

Insight Molecular Diagnostics' Interest Expense of $-0.10 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Insight Molecular Diagnostics and its competitors. Insight Molecular Diagnostics's current Interest Expense is $-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Insight Molecular Diagnostics stock overvalued right now?

Based on GuruFocus' analysis, Insight Molecular Diagnostics (IMDX) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.26, compared to a current price of $5.40 — trading 328.6% above its estimated fair value. The current Interest Expense is $-0.10 Mil. Insight Molecular Diagnostics' overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Insight Molecular Diagnostics (IMDX), the current Interest Expense is $-0.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insight Molecular Diagnostics (IMDX) Overvalued in 2026?

Based on GuruFocus' analysis, Insight Molecular Diagnostics stock appears to be overvalued. The current stock price of $5.40 is trading 328.6% above its estimated GF Value™ of $1.26. GuruFocus considers Insight Molecular Diagnostics to be Significantly Overvalued.

Key valuation signals for IMDX:

Interest Expense: $-0.10 Mil
GF Value™: $1.26 vs. price of $5.40 (328.6% above fair value)
GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the IMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insight Molecular Diagnostics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies BDSX XGN FONR BNR QUCY IDXG PRE PRPO MDXH BIOQ TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN

Other Exchanges 0KCC:UK 7OC0:Germany

Address 2 International Plaza Drive, Suite 510, Nashville, TN, USA, 37217

Website https://www.imdxinc.com

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

49GF Score

Get the complete analysis for IMDX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.40

Price

$1.26

GF Value

View IMDX Analysis

See Interest Expense data for all stocks →